OncoMatch

OncoMatch/Clinical Trials/NCT07790406

Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer

Is NCT07790406 recruiting? Yes, currently enrolling (Sep 2026).

RecruitingEuropean Institute of OncologyNCT07790406Data as of Sep 2026Location: Italy

Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.

Check if I qualify

Extracted eligibility criteria

Cancer type

Non-Small Cell Lung Carcinoma

Disease stage

Required: Stage I

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07790406 currently recruiting?

Yes, this trial is currently recruiting patients.

What disease stage is eligible?

Stage I is required.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify